Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Deglutition Disorders × Pravastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 3 Congenital Abnormalities 3 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Leukemia 2 Breast Neoplasms 2 Stomach Neoplasms 1 Prostatic Neoplasms 1 Myeloproliferative Disorders 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Deglutition Disorders 1 Cardiovascular Diseases 1 Carcinoma, Hepatocellular 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Radiotherapy 3 Cisplatin 3 Cryotherapy 2 Carboplatin 2 Acupuncture Therapy 2 tislelizumab 1 pembrolizumab 1 epigallocatechin gallate 1 durvalumab 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Tablets 1 Standard of Care 1 Resistance Training 1 Range of Motion, Articular 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Pravastatin 1 Parenteral Nutrition 1 Paclitaxel 1 Nivolumab 1 Niacinamide 1 Musculoskeletal Manipulations 1 Lead 1 Immunotherapy 1 Hyaluronic Acid 1 Gastropexy 1 Fundoplication 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07217938 2026-03-03

TRADstat

Peter MacCallum Cancer Centre, Australia

Phase 2 Recruiting

Deglutition Disorders, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡